Is nicotine bad for you?

A tin of nicotine pouches has no smoke, no tar and no ashtray smell, which is exactly why so many people have started treating it as the harmless option. The marketing leans into that gap hard. The science, as of 2026, does not let nicotine off the hook quite so easily. A major cardiology review has, for the first time, treated nicotine itself as a direct toxin to the cardiovascular system, not merely the thing that keeps people hooked on cigarettes.

The 2026 review that changed the framing

Researchers at University Medical Center Mainz, led by cardiologist Thomas Münzel, published a wide-ranging analysis in Nature Reviews Cardiology compiling molecular, clinical and biomarker evidence on nicotine and the heart. Münzel put the core finding plainly: "Nicotine is not an inert component that merely sustains addiction." The review describes nicotine triggering oxidative stress and inflammation that damages the lining of blood vessels, a process called endothelial dysfunction, which can progress toward high blood pressure, coronary disease, heart failure and stroke. Mechanistically, nicotine inhibits potassium channels in vascular smooth muscle, reduces protective compounds like nitric oxide, and releases endothelin-1, a vessel-constricting hormone. These effects showed up after a single exposure, not just after years of use.

Not all nicotine products carry equal risk

What the review adds that older nicotine warnings did not is a graded hierarchy. Combustion products, cigarettes and waterpipes, carry the greatest cardiovascular burden by a wide margin. Heated tobacco products and e-cigarettes sit in a moderate range. Oral nicotine products, the pouches now marketed heavily as a clean alternative, also carry a measurable cardiovascular risk, just a smaller one than the products that burn something. Münzel was direct about where the real danger concentrates: "The result is unambiguous: combustion causes the greatest toxicity." That is a genuinely useful distinction if you already use nicotine and are deciding what to switch to. It is not the same as a clean bill of health for any of it. [[INLINE]]

The addiction and brain-development side of the story

Cardiovascular risk is not the only concern, and it is not even the one researchers have studied longest. A transdisciplinary review in Neuroscience & Biobehavioral Reviews, drawing on decades of animal and human research, describes nicotine as a "subtle neuroteratogen" during fetal development, meaning it can alter brain circuitry without obvious structural damage. The same review reports that in animal models, nicotine exposure primes the brain to respond more strongly to other addictive drugs later on, through a mechanism involving histone modification, a proposed biological basis for nicotine acting as a gateway substance. In adolescents, whose brains continue developing into their mid-20s, nicotine exposure is linked to deficits in working memory, attention and impulse control.

Where the evidence is thinner

The same review is notably careful about what it does not know. Most of the nicotine-only evidence, separate from tobacco smoke, comes from animal studies or from adult smokeless-tobacco and nicotine-replacement users, a group that already differs from today's typical pouch or vape user in age and health history. The authors explicitly warn that conclusions from adult studies "cannot be extrapolated to adolescents" or to pregnant women. That gap matters because pouches and vapes are heavily marketed to, and used by, younger adults, precisely the group where the data is least complete and the stakes, given ongoing brain development, are highest.

What this means if you already use nicotine, or are thinking about starting

If you smoke and are weighing a switch, the evidence is reasonably clear that pouches, vapes or heated tobacco are a lower-harm move than continuing to smoke. That is consistent with how products like the ones covered in our look at athletic nicotine pouches get marketed, as a performance or lifestyle upgrade rather than a nicotine-replacement step. If you do not currently use nicotine in any form, the 2026 review gives you no real reason to start. Every delivery method studied showed measurable cardiovascular effects, and the addiction and brain-development risks apply well beyond cigarettes.

Our take

Nicotine is not the inert bystander it is sometimes sold as, even outside tobacco smoke. The 2026 cardiology review makes a genuinely new case that it independently harms blood vessels, and older developmental research backs up real concerns about addiction and brain effects, especially before age 25. None of that erases the much larger gap between nicotine-only products and cigarettes, which remain far more dangerous. But "less bad than smoking" and "good for you" are different claims, and the marketing around pouches often blurs them on purpose.

This is general information, not medical advice. Talk to a clinician before changing anything, especially if you are pregnant, nursing, or managing a condition.